Martegani E

References (3)

Title : Case Report: a novel PNPLA2 homozygous frameshift variant causing severe neutral lipid storage disease with myopathy (NLSDM) in a Moroccan patient - Faedo_2026_Front.Genet_17_1701218
Author(s) : Faedo E , Araujo Chumacero MM , Missaglia S , Lunati-Rozie A , Severa G , Onnee M , Das B , Martegani E , Lafage N , El Bejjani L , Barka I , Gobin-Limballe S , Badaoui B , Lefaucheur JP , Tavian D , Malfatti E
Ref : Front Genet , 17 :1701218 , 2026
Abstract :
PubMedSearch : Faedo_2026_Front.Genet_17_1701218
PubMedID: 42266408

Title : Case Report: Pathogenic PNPLA2 variants and nonsense-mediated mRNA decay result in an early-onset neutral lipid storage disease with myopathy - Missaglia_2025_Front.Genet_16_1642442
Author(s) : Missaglia S , Martegani E , Angelini C , Horvath R , Karcagi V , Pal E , Tavian D
Ref : Front Genet , 16 :1642442 , 2025
Abstract :
PubMedSearch : Missaglia_2025_Front.Genet_16_1642442
PubMedID: 40919432

Title : Peptide-nanoparticle ligation mediated by cutinase fusion for the development of cancer cell-targeted nanoconjugates - Galbiati_2015_Bioconjug.Chem_26_680
Author(s) : Galbiati E , Cassani M , Verderio P , Martegani E , Colombo M , Tortora P , Mazzucchelli S , Prosperi D
Ref : Bioconjug Chem , 26 :680 , 2015
Abstract :
PubMedSearch : Galbiati_2015_Bioconjug.Chem_26_680
PubMedID: 25741889